Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rational Design of Bioactive, Modularly Assembled Aminoglycosides Targeting the RNA that Causes Myotonic Dystrophy Type 1
Jessica L. Childs‐Disney, Raman Parkesh, Masayuki Nakamori, et al.
ACS Chemical Biology (2012) Vol. 7, Iss. 12, pp. 1984-1993
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Inforna 2.0: A Platform for the Sequence-Based Design of Small Molecules Targeting Structured RNAs
Matthew D. Disney, Audrey M. Winkelsas, Sai Pradeep Velagapudi, et al.
ACS Chemical Biology (2016) Vol. 11, Iss. 6, pp. 1720-1728
Open Access | Times Cited: 211
The Unstable Repeats—Three Evolving Faces of Neurological Disease
David L. Nelson, Harry T. Orr, Stephen T. Warren
Neuron (2013) Vol. 77, Iss. 5, pp. 825-843
Open Access | Times Cited: 198
MBNL proteins and their target RNAs, interaction and splicing regulation
Patryk Konieczny, Ewa Stepniak-Konieczna, Krzysztof Sobczak
Nucleic Acids Research (2014) Vol. 42, Iss. 17, pp. 10873-10887
Open Access | Times Cited: 184
RNA Structures as Mediators of Neurological Diseases and as Drug Targets
Viachaslau Bernat, Matthew D. Disney
Neuron (2015) Vol. 87, Iss. 1, pp. 28-46
Open Access | Times Cited: 130
RNA Toxicity and Missplicing in the Common Eye Disease Fuchs Endothelial Corneal Dystrophy
Jintang Du, Ross A. Aleff, Elisabetta Soragni, et al.
Journal of Biological Chemistry (2015) Vol. 290, Iss. 10, pp. 5979-5990
Open Access | Times Cited: 127
Identification and Characterization of Modified Antisense Oligonucleotides Targeting DMPK in Mice and Nonhuman Primates for the Treatment of Myotonic Dystrophy Type 1
Sanjay K. Pandey, Thurman M. Wheeler, Samantha L. Justice, et al.
Journal of Pharmacology and Experimental Therapeutics (2015) Vol. 355, Iss. 2, pp. 329-340
Open Access | Times Cited: 110
Analysis of carbohydrates and glycoconjugates by matrix‐assisted laser desorption/ionization mass spectrometry: An update for the period 2005–2006
David J. Harvey
Mass Spectrometry Reviews (2010) Vol. 30, Iss. 1, pp. 1-100
Closed Access | Times Cited: 93
RNA-Binding Proteins: Splicing Factors and Disease
Alger M. Fredericks, Kamil J. Cygan, Brian Brown, et al.
Biomolecules (2015) Vol. 5, Iss. 2, pp. 893-909
Open Access | Times Cited: 87
Induction and reversal of myotonic dystrophy type 1 pre-mRNA splicing defects by small molecules
Jessica L. Childs‐Disney, Ewa Stepniak-Konieczna, Tuan Anh Tran, et al.
Nature Communications (2013) Vol. 4, Iss. 1
Open Access | Times Cited: 83
New developments in RAN translation: insights from multiple diseases
John D. Cleary, Laura P.W. Ranum
Current Opinion in Genetics & Development (2017) Vol. 44, pp. 125-134
Open Access | Times Cited: 82
New trends in the use of aminoglycosides
Marina Y. Fosso, Yijia Li, Sylvie Garneau‐Tsodikova
MedChemComm (2014) Vol. 5, Iss. 8, pp. 1075-1091
Open Access | Times Cited: 77
Structure based approaches for targeting non-coding RNAs with small molecules
Matthew D. Shortridge, Gabriele Varani
Current Opinion in Structural Biology (2015) Vol. 30, pp. 79-88
Open Access | Times Cited: 74
Synthetic small-molecule RNA ligands: future prospects as therapeutic agents
Audrey Di Giorgio, Maria Duca
MedChemComm (2019) Vol. 10, Iss. 8, pp. 1242-1255
Open Access | Times Cited: 68
Structure of the Myotonic Dystrophy Type 2 RNA and Designed Small Molecules That Reduce Toxicity
Jessica L. Childs‐Disney, Ilyas Yildirim, HaJeung Park, et al.
ACS Chemical Biology (2013) Vol. 9, Iss. 2, pp. 538-550
Open Access | Times Cited: 69
Methods to enable the design of bioactive small molecules targeting RNA
Matthew D. Disney, Ilyas Yildirim, Jessica L. Childs‐Disney
Organic & Biomolecular Chemistry (2013) Vol. 12, Iss. 7, pp. 1029-1039
Open Access | Times Cited: 66
Oral administration of erythromycin decreases RNA toxicity in myotonic dystrophy
Masayuki Nakamori, Katarzyna Taylor, Hideki Mochizuki, et al.
Annals of Clinical and Translational Neurology (2015) Vol. 3, Iss. 1, pp. 42-54
Open Access | Times Cited: 60
Two-dimensional combinatorial screening enables the bottom-up design of a microRNA-10b inhibitor
Sai Pradeep Velagapudi, Matthew D. Disney
Chemical Communications (2014) Vol. 50, Iss. 23, pp. 3027-3027
Open Access | Times Cited: 56
A Chemical Inhibitor of the Skp2/p300 Interaction that Promotes p53‐Mediated Apoptosis
Misook Oh, Ji Hoon Lee, Heejo Moon, et al.
Angewandte Chemie International Edition (2015) Vol. 55, Iss. 2, pp. 602-606
Closed Access | Times Cited: 55
HIV-1 Frameshift RNA-Targeted Triazoles Inhibit Propagation of Replication-Competent and Multi-Drug-Resistant HIV in Human Cells
Thomas A. Hilimire, Jeffrey M. Chamberlain, Viktoriya Anokhina, et al.
ACS Chemical Biology (2017) Vol. 12, Iss. 6, pp. 1674-1682
Open Access | Times Cited: 50
RNA structures in alternative splicing and back‐splicing
Bingbing Xu, Yijun Meng, Yongfeng Jin
Wiley Interdisciplinary Reviews - RNA (2020) Vol. 12, Iss. 1
Closed Access | Times Cited: 49
Molecular Therapies for Myotonic Dystrophy Type 1: From Small Drugs to Gene Editing
Mariapaola Izzo, Jonathan Battistini, Claudia Provenzano, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4622-4622
Open Access | Times Cited: 24
Analysis of carbohydrates and glycoconjugates by matrix‐assisted laser desorption/ionization mass spectrometry: An update for 2011–2012
David J. Harvey
Mass Spectrometry Reviews (2015) Vol. 36, Iss. 3, pp. 255-422
Closed Access | Times Cited: 44
Features of Modularly Assembled Compounds That Impart Bioactivity Against an RNA Target
Suzanne G. Rzuczek, Yu Gao, Zhenzhi Tang, et al.
ACS Chemical Biology (2013) Vol. 8, Iss. 10, pp. 2312-2321
Open Access | Times Cited: 39
Treatment of Type 1 Myotonic Dystrophy by Engineering Site-specific RNA Endonucleases that Target (CUG)n Repeats
Wenjing Zhang, Yang Wang, Shuyun Dong, et al.
Molecular Therapy (2013) Vol. 22, Iss. 2, pp. 312-320
Open Access | Times Cited: 36
RNA FISH for detecting expanded repeats in human diseases
Martyna O. Urbanek, Włodzimierz J. Krzyżosiak
Methods (2015) Vol. 98, pp. 115-123
Closed Access | Times Cited: 30
Page 1 - Next Page

Scroll to top